1. Home
  2. ALKS vs TKC Comparison

ALKS vs TKC Comparison

Compare ALKS & TKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • TKC
  • Stock Information
  • Founded
  • ALKS 1987
  • TKC 1993
  • Country
  • ALKS Ireland
  • TKC Turkey
  • Employees
  • ALKS N/A
  • TKC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • TKC Telecommunications Equipment
  • Sector
  • ALKS Health Care
  • TKC Telecommunications
  • Exchange
  • ALKS Nasdaq
  • TKC Nasdaq
  • Market Cap
  • ALKS 5.1B
  • TKC 5.2B
  • IPO Year
  • ALKS 1991
  • TKC 2000
  • Fundamental
  • Price
  • ALKS $29.05
  • TKC $6.21
  • Analyst Decision
  • ALKS Buy
  • TKC
  • Analyst Count
  • ALKS 12
  • TKC 0
  • Target Price
  • ALKS $40.00
  • TKC N/A
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • TKC 1.1M
  • Earning Date
  • ALKS 07-23-2025
  • TKC 05-09-2025
  • Dividend Yield
  • ALKS N/A
  • TKC 3.81%
  • EPS Growth
  • ALKS N/A
  • TKC 3.80
  • EPS
  • ALKS 2.09
  • TKC 0.28
  • Revenue
  • ALKS $1,513,770,000.00
  • TKC $4,535,065,308.00
  • Revenue This Year
  • ALKS N/A
  • TKC $30.06
  • Revenue Next Year
  • ALKS $4.25
  • TKC $30.03
  • P/E Ratio
  • ALKS $13.86
  • TKC $8.90
  • Revenue Growth
  • ALKS N/A
  • TKC 2.83
  • 52 Week Low
  • ALKS $22.90
  • TKC $5.54
  • 52 Week High
  • ALKS $36.45
  • TKC $8.47
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 40.26
  • TKC 55.36
  • Support Level
  • ALKS $29.26
  • TKC $5.62
  • Resistance Level
  • ALKS $29.53
  • TKC $5.94
  • Average True Range (ATR)
  • ALKS 0.69
  • TKC 0.10
  • MACD
  • ALKS -0.14
  • TKC 0.02
  • Stochastic Oscillator
  • ALKS 14.74
  • TKC 86.36

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

Share on Social Networks: